Literature DB >> 31807525

Preoperative assessment of lymph node metastasis in clinically node-negative rectal cancer patients based on a nomogram consisting of five clinical factors.

Chi Zhou1,2,3, Hua-Shan Liu1,2,3, Xuan-Hui Liu1,2,3, Xiao-Bin Zheng1,2,3, Tuo Hu1,2,3, Zhen-Xing Liang1,2,3, Xiao-Wen He1,2, Xiao-Sheng He1,2, Jian-Cong Hu1,2, Xiao-Jian Wu1,2, Xian-Rui Wu1,2,3, Ping Lan1,2,3.   

Abstract

BACKGROUND: Currently, reliable approaches for accurate assessment of lymph node metastases (LNM), which is an important indication of preoperative chemoradiotherapy (CRT), are not available for clinically node-negative rectal cancer patients. This study aims to identify clinical factors associated with LNM and to establish a nomogram for LNM prediction in clinically node-negative rectal cancer patients.
METHODS: The least absolute shrinkage and selection operator (LASSO) aggression and multivariate logistic regression analyses were applied to identify clinical factors associated with LNM. A nomogram was established to predict the probability of LNM in clinically node-negative rectal cancer patients based on the multivariate logistic regression model.
RESULTS: Six potential risk factors were selected on the basis of LASSO aggression analysis, and five of them were identified as independent risk factors for LNM based on multivariate analysis, including MRI-reported tumor location, clinical T classification, MRI-reported tumor diameter, white blood cell count (WBC), and preoperative elevated tumor markers. A nomogram consisting of the five clinical factors was established and showed good discrimination. Decision curve analysis demonstrated that the established nomogram was reliable and accurate for LNM prediction in clinically node-negative rectal cancer patients.
CONCLUSIONS: A nomogram based on five clinical factors, including MRI-reported tumor location, clinical T classification, MRI-reported tumor diameter, WBC, and preoperative elevated tumor markers, are useful for assessing LNM in clinically node-negative rectal cancer patients, which is important for preoperative CRT regimens. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Lymph node metastasis (LNM); nomogram; rectal cancer; risk factor

Year:  2019        PMID: 31807525      PMCID: PMC6861767          DOI: 10.21037/atm.2019.09.127

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  52 in total

1.  Stage I rectal cancer: identification of high-risk patients.

Authors:  D Blumberg; P B Paty; A I Picon; J G Guillem; D S Klimstra; B D Minsky; S H Quan; A M Cohen
Journal:  J Am Coll Surg       Date:  1998-05       Impact factor: 6.113

2.  Is preoperative chemoradiotherapy still the treatment of choice for rectal cancer?

Authors:  Bruce D Minsky
Journal:  J Clin Oncol       Date:  2009-09-21       Impact factor: 44.544

3.  Metastatic potential in T1 and T2 colorectal cancer.

Authors:  Wen-Liang Fang; Shih-Ching Chang; Jen-Kou Lin; Haunn-Sheng Wang; Shung-Haur Yang; Jen-Kae Jiang; Wei-Chone Chen; Tzu-Chen Lin
Journal:  Hepatogastroenterology       Date:  2005 Nov-Dec

4.  Accuracy of preoperative MRI in predicting pathology stage in rectal cancers: node-for-node matched histopathology validation of MRI features.

Authors:  Jun Seok Park; Yun-Jin Jang; Gyu-Seog Choi; Soo Yeun Park; Hye Jin Kim; Hyun Kang; Seung Hyun Cho
Journal:  Dis Colon Rectum       Date:  2014-01       Impact factor: 4.585

5.  Patterns of lymphatic spread in rectal cancer. A topographical analysis on lymph node metastases.

Authors:  W H Steup; Y Moriya; C J H van de Velde
Journal:  Eur J Cancer       Date:  2002-05       Impact factor: 9.162

6.  Cancer statistics in China, 2015.

Authors:  Wanqing Chen; Rongshou Zheng; Peter D Baade; Siwei Zhang; Hongmei Zeng; Freddie Bray; Ahmedin Jemal; Xue Qin Yu; Jie He
Journal:  CA Cancer J Clin       Date:  2016-01-25       Impact factor: 508.702

7.  A simple scoring system based on clinical features to predict locally advanced rectal cancers.

Authors:  Guoxiang Cai; Ye Xu; Xiaoli Zhu; Junjie Peng; Zuofeng Li; Changchun Xiao; Xiang Du; Ji Zhu; Peng Lian; Weiqi Sheng; Zuqing Guan; Sanjun Cai
Journal:  J Gastrointest Surg       Date:  2009-04-15       Impact factor: 3.452

Review 8.  Cancer-related inflammation.

Authors:  Alberto Mantovani; Paola Allavena; Antonio Sica; Frances Balkwill
Journal:  Nature       Date:  2008-07-24       Impact factor: 49.962

9.  Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines.

Authors:  R Kikuchi; M Takano; K Takagi; N Fujimoto; R Nozaki; T Fujiyoshi; Y Uchida
Journal:  Dis Colon Rectum       Date:  1995-12       Impact factor: 4.585

10.  White blood cell count and the risk of colon cancer.

Authors:  Yong-Jae Lee; Hye-Ree Lee; Chung-Mo Nam; Ue-Kyoung Hwang; Sun-Ha Jee
Journal:  Yonsei Med J       Date:  2006-10-31       Impact factor: 2.759

View more
  4 in total

1.  Quantitative CT measurement of left colonic and pelvic mesenteric adipose volume in radiation proctitis.

Authors:  Yonghua Cai; Tenghui Ma; Qinghua Zhong; Qiyuan Qin; Wuteng Cao; Zhanzhen Liu; Jia Ke; Hui Wang
Journal:  Ann Transl Med       Date:  2020-07

2.  Preoperative volumetric synthetic magnetic resonance imaging of the primary tumor for a more accurate prediction of lymph node metastasis in rectal cancer.

Authors:  Li Zhao; Meng Liang; Zhuo Shi; Lizhi Xie; Hongmei Zhang; Xinming Zhao
Journal:  Quant Imaging Med Surg       Date:  2021-05

3.  Development of a Nomogram Combining Clinical Risk Factors and Dual-Energy Spectral CT Parameters for the Preoperative Prediction of Lymph Node Metastasis in Patients With Colorectal Cancer.

Authors:  Yuntai Cao; Jing Zhang; Haihua Bao; Guojin Zhang; Xiaohong Yan; Zhan Wang; Jialiang Ren; Yanjun Chai; Zhiyong Zhao; Junlin Zhou
Journal:  Front Oncol       Date:  2021-09-22       Impact factor: 6.244

4.  Predicting metachronous liver metastasis in patients with colorectal cancer: development and assessment of a new nomogram.

Authors:  Mengdi Hao; Huimin Li; Kun Wang; Yin Liu; Xiaoqing Liang; Lei Ding
Journal:  World J Surg Oncol       Date:  2022-03-12       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.